Publication | Closed Access
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin
54
Citations
54
References
2021
Year
NanomedicineType 1Bile-acid-polymer NanocarriersEngineeringMedicineInsulin ManagementDiabetesNano-drug DeliveryBiomedical EngineeringInsulin DeliveryPharmacologyImmunomodulatory ControlInsulin Signaling
| Year | Citations | |
|---|---|---|
Page 1
Page 1